Lucie H.
- Country
- Germany
- Department
- Dermatology and allergology
Research Overview
- A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma (KEYVIBE-010)
- A Phase I Study to Evaluate the Safety and Efficacy of KUP-101A in Patients with Advanced Solid Tumors Including Cutaneous and Mucosal Melanoma and Squamous Cell Carcinoma
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
Data & Insights
Has run more than one trial at 178 of 359 partner sites.
Specializations
Melanoma Research
This investigator specializes in treating various stages of melanoma, with particular focus on advanced and metastatic cases. Their research encompasses both resectable and unresectable melanoma, including specific studies on BRAF V600E/K mutation-positive cases.
- Stage II-IV Melanoma Management
- Post-surgical Adjuvant Therapy
- Advanced Melanoma Treatment
Cutaneous Cancers
The investigator conducts research in various forms of skin cancer, including cutaneous squamous cell carcinoma (CSCC) and cutaneous T-cell lymphoma. They study innovative approaches for treating both localized and advanced cases.
- Squamous Cell Carcinoma Treatment
- T-Cell Lymphoma Management
- High-risk Skin Cancer Therapy
Immunotherapy Applications
The investigator explores various immunotherapy approaches in skin cancer treatment, including checkpoint inhibitor therapy and novel combinations of immunotherapeutic agents. Their work includes studies of treatment-resistant cases and innovative combination therapies.
- Novel Immunotherapy Combinations
- Resistance Management Strategies
- Adjuvant Immunotherapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.